Health & Medicine
No.1, South Yangtze River Road, Taizhou, Jiangsu, China
Our Yangtze River Pharmaceutical Group (hereinafter referred to as YRPG) is a large-scale pharmaceutical group with 40 years history in China. Our headquarter is located in Taizhou, Jiangsu Province, and owns more than 20 subsidiary companies which locate in Beijing, Shanghai, Guangzhou, Nanjing and Chengdu. YRPG has more than 7, 000 employees, 7 billion RMB total assets and occupies over 2, 000, 000 square meters. The main products of YRPG are Traditional Chinese Medicines (TCM), western medicines and biological agents, and our marketing network spreads to every city, every province and every autonomous region of China. YRPG was awarded the title of "Innovative Enterprise" in 2008, and ranked "Top 500 Chinese Enterprises". Besides these, the operational performance of the Group has achieved top 1 among Chinese Pharmaceutical Industry for many years continuously.
You can see the New Drug Research Institutes of Yangtze River Pharmaceutical Group in Beijing, Shanghai, Taizhou and so on, and we own research platforms such as State-level Enterprise Technology Center, State Key Lab of New Technology of Pharmaceutical Preparation and National Engineering Research Center of TCM. Jiangsu (Yangtze River) New Drug Research Institute owns more than 300 professional staffs, who have research innovation ability of TCM, western medicine and biological agents. In the new drug research field, we mainly focus on the research of anti-cancer, antibiotics, digestive system, cardio-cerebral vascular system, endocrine system and so on, devoted ourselves to the research of original new drugs. We will practice the strategy of development and innovation, seek international cooperation of pharmaceutical research positively and hope the elite from overseas joining us to create a great cause sincerely.
With the group spirit "Seeking progress all the time, safeguarding all human beings", YRPG is dedicated to serving all human beings to create a healthy life with a professional and responsible attitude, and strides towards the goal to become an international top pharmaceutical enterprise.